Vedantra Pharmaceuticals Secures $750,000 New Financing

  • Feed Type
  • Date
  • Company Name
    Vedantra Pharmaceuticals
  • Mailing Address
    One Kendall Square Cambridge, MA 02139 USA
  • Company Description
    Vedantra Pharmaceuticals is applying novel nanotechnology-based approaches to develop vaccines for infectious disease and cancer.
  • Website
  • Transaction Type
    Venture Equity, Debt
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 1 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy